Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6703)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cholongitas E, Pipili C, Papatheodoridis G. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients. World J Gastroenterol 2015; 21(32): 9526-9533 [PMID: 26327760 DOI: 10.3748/wjg.v21.i32.9526] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i32/9526.htm |
| Number | Citing Articles |
| 1 |
Tomohiro Tanaka, Nobuhisa Akamatsu, Junichi Kaneko, Junichi Arita, Sumihito Tamura, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo. Daclatasvir and asunaprevir for recurrent hepatitis C following living donor liver transplantation with HIV co‐infection. Hepatology Research 2016; 46(8): 829 doi: 10.1111/hepr.12614
|
| 2 |
José Castellote, Francisco Gea, Luis Enrique Morano, Rosa M. Morillas, Juan Antonio Pineda, Mercedes Vergara, María Buti. Factores que influyen en la curación de la hepatitis C en la era de los antivirales de acción directa. Gastroenterología y Hepatología 2019; 42: 1 doi: 10.1016/S0210-5705(20)30181-3
|
| 3 |
Aurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, Claire Laforest, Audrey Lavenu, Hélène Danjou, Sylvie Radenne, Vincent Leroy, Pauline Houssel-Debry, Christophe Duvoux, Nassim Kamar, Victor De Ledinghen, Valérie Canva, Filomena Conti, François Durand, Louis D’Alteroche, Danielle Botta-Fridlund, Christophe Moreno, Carole Cagnot, Didier Samuel, Claire Fougerou-Leurent, Georges-Philippe Pageaux, Jean-Charles Duclos-Vallée, Anne-Marie Taburet, Audrey Coilly. Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort. European Journal of Clinical Pharmacology 2019; 75(11): 1555 doi: 10.1007/s00228-019-02725-x
|
| 4 |
G. Sanchez Antolin, M. Testillano, J.M. Pascasio, I. Narvaez Rodriguez, M. Prieto, A. Otero, J.I. Herrero, M. Londoño, I. Fernandez Vazquez, L. Castells, Xavier Xiol, Maria Luisa Gonzalez Dieguez, Mario Romero Cristobal, Jose Antonio Pons Miñano, Sonia Pascual Bartolome, Jose Luis Montero, Ana Arencibia, Sara Lorente, Esther Molina, Maria Dolores Espinosa, Valentin Cuervas-Mons, Emilio Fabrega Garcia. Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort. Transplantation Proceedings 2016; 48(9): 3013 doi: 10.1016/j.transproceed.2016.08.034
|
| 5 |
Tilman Sauerbruch, Beate Appenrodt. Therapie-Handbuch - Gastroenterologie und Hepatologie. 2021; : 383 doi: 10.1016/B978-3-437-23847-5.00054-5
|
| 6 |
Xiaobo Zhu, Mingqi Wang, Mei Liu, Xinghao Yu, Peng Huang. Efficacy and safety of direct-acting antivirals for treatment-naive patients with genotype 1 hepatitis C virus infection. Personalized Medicine 2019; 16(5): 421 doi: 10.2217/pme-2018-0121
|
| 7 |
B.-H. Jung, J.-I. Park, S.-G. Lee. Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report. Transplantation Proceedings 2018; 50(9): 2877 doi: 10.1016/j.transproceed.2018.03.057
|
| 8 |
Islam El-Garawani, Sobhy Hassab El-Nabi, Marwa Gadallah, Eman Abdelsameea. Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients. Immunological Investigations 2021; 50(1): 12 doi: 10.1080/08820139.2020.1722158
|
| 9 |
Suresh Gorka, Ghulam M. Gulzar, Ghulam N. Yattoo, Jaswinder S. Sodhi, Gulzar A. Dar, Mushtaq A. Laway, Saurabh Kaushik, Neeraj Dhar, Syed Mushfiq, Riffat A. Aziz. Genotype 1 and 3 Response to Velpatasvir and Sofosbuvir in Chronic Hepatitis C in the Kashmiri Population: An Observational Study. Journal of Clinical and Experimental Hepatology 2020; 10(2): 155 doi: 10.1016/j.jceh.2019.07.003
|
| 10 |
|
| 11 |
Ewelina Krol, Gabriela Pastuch-Gawolek, Binay Chaubey, Gabriela Brzuska, Karol Erfurt, Boguslaw Szewczyk. Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral Compounds. Molecules 2018; 23(6): 1435 doi: 10.3390/molecules23061435
|
| 12 |
Daniel Esteban Pino Marín, Pedro Amariles, Jaime Alberto Peláez Alvárez, Gloria Priscilla Alvárez Osorio, Juliana González Ceballos. Aproximación para establecer y evaluar la relevancia clínica de las interacciones medicamentosas en el tratamiento de pacientes infectados con virus de hepatitis C, revisión estructurada (actualización 2015 – 2017). Revista Colombiana de Gastroenterología 2019; 34(2): 159 doi: 10.22516/25007440.252
|
| 13 |
Aldo Bonaventura, Fabrizio Montecucco. Sofosbuvir/velpatasvir: A promising combination. World Journal of Hepatology 2016; 8(19): 785-789 doi: 10.4254/wjh.v8.i19.785
|
| 14 |
Tomohide Hori, Yasuharu Onishi, Hideya Kamei, Nobuhiko Kurata, Masatoshi Ishigami, Yoji Ishizu, Yasuhiro Ogura. Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma. American Journal of Case Reports 2016; 17: 597 doi: 10.12659/AJCR.898427
|
| 15 |
A.E. Shafii, D.D. Harris, M. Baz. Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report. Transplantation Proceedings 2017; 49(7): 1682 doi: 10.1016/j.transproceed.2017.06.002
|
| 16 |
Sunil Taneja, Ajay Duseja, Arka De, Vivek Kumar, Raja Ramachandran, Ashish Sharma, Radha K Dhiman, Krishan L Gupta, Yogesh Chawla. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients. Nephrology 2018; 23(9): 876 doi: 10.1111/nep.13109
|
| 17 |
Xavier Forns, Marina Berenguer, Kerstin Herzer, Martina Sterneck, Maria Francesca Donato, Pietro Andreone, Stefano Fagiuoli, Tomasz Cieciura, Magdalena Durlik, Jose Luis Calleja, Zoe Mariño, Umesh Shukla, Thierry Verbinnen, Oliver Lenz, Sivi Ouwerkerk‐Mahadevan, Monika Peeters, Katrien Janssen, Ronald Kalmeijer, Wolfgang Jessner. Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study. Transplant Infectious Disease 2017; 19(3) doi: 10.1111/tid.12696
|
| 18 |
N. Blank, H.-M. Lorenz. Kryoglobulinämische Vaskulitiden. Zeitschrift für Rheumatologie 2016; 75(3): 303 doi: 10.1007/s00393-016-0076-4
|
| 19 |
Shinya Maekawa, Mitsuaki Sato, Natsuhiko Kuratomi, Taisuke Inoue, Yuichiro Suzuki, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Tadashi Sato, Minoru Sakamoto, Miyako Murakawa, Mina Nakagawa, Yasuhiro Asahina, Nobuyuki Enomoto. Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C. Journal of Gastroenterology 2018; 53(6): 780 doi: 10.1007/s00535-017-1405-3
|
| 20 |
Kelly H. Schlendorf, Sandip Zalawadiya, Ashish S. Shah, Mark Wigger, Chan Y. Chung, Sarah Smith, Matthew Danter, Chun W. Choi, Mary E. Keebler, D. Marshall Brinkley, Suzanne Brown Sacks, Henry Ooi, Roman Perri, Joseph A. Awad, Samuel Lewis, Rachel Hayes, Heather O’Dell, Callie Darragh, Alicia Carver, Cori Edmonds, Shelley Ruzevich-Scholl, JoAnn Lindenfeld. Early outcomes using hepatitis C–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. The Journal of Heart and Lung Transplantation 2018; 37(6): 763 doi: 10.1016/j.healun.2018.01.1293
|
| 21 |
Kiyohiko Omichi, Nobuhisa Akamatsu, Kazuhiro Mori, Junichi Togashi, Junichi Arita, Junichi Kaneko, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo. Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation. Hepatology Research 2017; 47(11): 1093 doi: 10.1111/hepr.12845
|